Abstract
Purpose
We describe the epidemiology of invasive Haemophilus influenzae disease (IHD) among adults in Japan.
Methods
Data for 200 adult IHD patients in 2014–2018 were analyzed. The capsular type of H. influenzae was determined by bacterial agglutination and polymerase chain reaction (PCR), and non-typeable Haemophilus influenzae (NTHi) was identified by PCR.
Results
The annual incidence of IHD (cases per 100,000 population) was 0.12 for age 15–64 years and 0.88 for age ≥ 65 years in 2018. The median age was 77 years, and 73.5% were aged ≥ 65 years. About one-fourth of patients were associated with immunocompromising condition. The major presentations were pneumonia, followed by bacteremia, meningitis and other than pneumonia or meningitis (other diseases). The case fatality rate (CFR) was 21.2% for all cases, and was significantly higher in the ≥ 65-year group (26.1%) than in the 15–64-year group (7.5%) (p = 0.013). The percentage of cases with pneumonia was significantly higher in the ≥ 65-year group than in the 15–64-year group (p < 0.001). The percentage of cases with bacteremia was significantly higher in the 15–64-year group than in the ≥ 65-year group (p = 0.027). Of 200 isolates, 190 (95.0%) were NTHi strains, and the other strains were encapsulated strains. 71 (35.5%) were resistant to ampicillin, but all were susceptible to ceftriaxone.
Conclusion
The clinical presentations of adult IHD patients varied widely; about three-fourths of patients were age ≥ 65 years and their CFR was high. Our findings support preventing strategies for IHD among older adults, including the development of NTHi vaccine.
Similar content being viewed by others
References
Murphy TF. Haemophilus species, including H. influenzae and H. ducryi (Chancroid). In: Bennet JE, Dolin R, Blaser MJ, editors. Principles and practices of infectious diseases. 9th ed. Philadelphia: Elsevier Saunders; 2020. p. 2743–52.
Murphy TF, Faden H, Balaletz LO, Kyd JM, Forsgren A, Camos J, et al. Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr Infect Dis J. 2009;28:43–8. https://doi.org/10.1097/INF.0b013e318184dba2.
Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zell ER, Broome CV, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. 1993;269:221–6. https://doi.org/10.1001/jama.1993.03500020055031.
Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev. 2000;13:302–17. https://doi.org/10.1128/CMR.13.2.302.
Berndsen MR, Erlendsdóttir H, Gottfredsson M. Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study. Clin Microbiol Infect. 2012;18:918–23. https://doi.org/10.1111/j.1469-0691.2011.03700.x.
MacNeil JR, Cohn AC, Farley M, Mair R, Baumbach J, Bennet N, et al. Current epidemiology and trends in invasive Haemophilus influenzae disease-United States, 1989–2008. Clin Infect Dis. 2011;53:1230–6. https://doi.org/10.1093/cid/cir735.
Dworkin MS, Park L, Borchardt SM. The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons > or = 65 years old. Clin Infect Dis. 2007;44:810–6. https://doi.org/10.1086/511861.
Ladhani S, Slack MP, Heath PT, von Gottberg A, Chandra M, Ramsay ME, et al. Invasive Haemophilus influenzae disease, Europe, 1996–2006. Emerg Infect Dis. 2010;16:455–63. https://doi.org/10.3201/eid1603.090290.
van Wessel K, Rodenburg GD, Veemhoven RH, Spanjaard L, van der Ende A, Sander EAM. Nontypeable Haemophilus influenzae invasive disease in The Netherlands: a retrospective surveillance study 2001–2008. Clin Infect Dis. 2011;53:e1-7. https://doi.org/10.1093/cid/cir268.
Whittaker R, Economopoulou A, Dias JG, Bancroft E, Rammliden M, Celentano LP, European Centre for Disease Prevention and Control Country Experts for Invasive Haemophilus influenzae Disease. Epidemiology of invasive haemophilus influenzae disease, Europe, 2007–2014. Emerg Infect Dis. 2017;23:396–404. https://doi.org/10.3201/eid2303.161552.
Giufre M, Fabiani M, Cardines R, Riccardo F, Caporali MG, D’Ancona F, et al. Increasing trend in invasive non-typeable Haemophilus influenzae disease and molecular characterization of the isolates, 2012–2016. Vaccine. 2018;26:6615–22. https://doi.org/10.1016/j.vaccine.2018.09.060.
Soeters HM, Blain A, Pondo T, Doran B, Farley MM, Harrison LH, et al. Current epidemiology and trends in invasive Haemophilus influenzae disease–United States, 2009–2015. Clin Infect Dis. 2018;67:881–9. https://doi.org/10.1093/cid/ciy187.
Takla A, Schonfeld V, Claus H, Krones M, an der Heiden M, Koch J, et al. Invasive Haemophilus influenzae infections in Germany after the introduction of routine childhood immunization. Open Forum Infect Dis. 2020. https://doi.org/10.1093/ofid/ofaa444.
Deghmane AE, Hong E, Chehboub S, Terrade A, Falguieres M, Sort M, et al. High diversity of invasive Haemophilus influenzae isolates in France and the emergence of resistance to the third generation cephalosporins by alteration of ftsl gene. J Infect. 2019;79:7–14. https://doi.org/10.1016/j.jinf.2019.05.007.
Heliodoro CIM, Bettencourt CR. Bajanca-Lavado MP & Portuguese Group for the Study of Haemophilus influenzae invasive infection. Eur J Clin Miclobiol Infect. 2020;39:1471–80.
Collins S, Litt DJ, Flynn S, Ramsay ME, Slack MPE, Ladhani SN. Neonatal invasive Haemophilus influenzae disease in England and Wales: epidemiology, clinical characteristics, and outcome. Clin Infect Dis. 2015;60:1786–92.
Collins S, Vickers A, Ladhani SN, Flynn S, Platt S, Ramsay ME, et al. Clinical and molecular epidemiology of childhood invasive nontypeable Haemophilus influenzae disease in England and Wales. Pediatr Infect Dis J. 2016;35:e76-84. https://doi.org/10.1097/INF.0000000000000996.
Soeters HM, Olver SE, Plumb ID, Blain AE, Zulz T, Simons BC, et al. Epidemiology of invasive Haemophilus influenzae serotype a disease–United States, 2008–2017. Clin Infect Dis. 2021;73:e371–9. https://doi.org/10.1093/cid/ciaa875.
Puig C, Grau I, Marti S, Tubau F, Calatayud L, Pallares R, et al. Clinical and molecular epidemiology of Haemophilus influenzae causing invasive disease in adult patients. PLoS One. 2014;9: e112711. https://doi.org/10.1371/journal.pone.0112711.
World Health Organization (WHO). WHO Position paper on Haemophilus influenzae type b conjugate vaccines. Wkl Epidemiol Rec. 2006; 81: 445–52. https://www.who.int/wer/2006/wer8147.pdf?ua=1
Ladhani S, Ramsay ME, Chandra M, Slack MP, for EU-IBIS. No evidence for Haemophilus influenzae serotype replacement in Europe after introduction of the Hib conjugate vaccine. Lancet Infect Dis. 2008;8:275–6. https://doi.org/10.1016/S1473-3099(08)70078-1.
Suga S, Ishiwada N, Sasaki Y, Akeda H, Nishi J, Okada K, et al. A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan. Vaccine. 2018;36:5678–84. https://doi.org/10.1016/j.vaccine.2018.08.029.
Wang CC, Kuo HY, Chiang DH, Tsai CC, Lin ML, Chan YJ, et al. Invasive Haemophilus influenzae disease in adults in Taiwan. J Microbiol Immunol Infect. 2008;41:209–14.
Shimbashi R, Chang B, Tanabe Y, Takeda H, Watanabe H, Kubota T, et al. Epidemiological and clinical features of invasive pneumococcal disease caused by serotype 12F in adults, Japan. PLoS One. 2019. https://doi.org/10.1371/journal.pone.0212418.
Statistics Bureau of Japan. Population Estimates. https://www.stat.go.jp/english/data/jinsui/ [accessed 10 Jan. 2022].
Norskov-Lauritsen N. Detection of cryptic genospecies misidentified as Haemophilus influenzae in routine clinical samples by assessment of marker genes fuk, hap, and sodC. J Clini Microbiol. 2009;47:2590–2.
Zhang B, Kunde D, Tristram S. Haemophilus haemolyticus is infrequently misidentified as Haemophilus influenzae in diagnostic specimens in Australia. Diagn Microbiol Infect Dis. 2014;80:272–3.
Falla TJ, Crook DW, Brophy LN, Maskell D, Kroll JS, Moxon ER, et al. PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol. 1994;32:2382–6. https://doi.org/10.1128/jcm.32.10.2382-2386.1994.
Davis GS, Sandstedt SA, Patel M, Marrs CF, Gilsdorf JR. Use of bexB to detect the capsular locus in Haemophilus influenzae. J Clin Microbiol. 2011;49:2594–601. https://doi.org/10.1128/JCM.02509-10.
Clinical and Laboratory Standards Institute (CLSI): Performance standards for antimicrobial susceptibility testing; M100, 30th ed. Wayne, Pennsylvania, USA. 2020. https://clsi.org/media/3481/m100ed30_sample.pdf
O’Callaghan CH, Morris A, Kirby SM, Shingler AH. Novel method for detection of β-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother. 1972;1:283–8. https://doi.org/10.1128/AAC.1.4.283.
Chang B, Tamura K, Fujikura H, Watanabe H, Tanabe Y, Kuronuma K, et al. Pneumococcal meningitis in adults in 2014–2018 after Introduction of Pediatric 13-valent pneumococcal conjugate vaccine in Japan. Sci Rep. 2022;12:3066.
Sakamoto S, Sakamoto N. Bacterial meningitis caused by β-lactamase non-producing ampicillin-resistant Haemophilus influenzae type f in an immunocompetent woman. Intern Med. 2019;58:307–10. https://doi.org/10.2169/internalmedicine.0597-17.
Hasegawa Y, Arunuma Y, Tanaka S, Tono T, Tanaka T, Muramatsu T, et al. Haemophilus influenzae non-type b infection in an adult patient with systemic lupus erythematosus. Intern Med. 2020;59:3097–101. https://doi.org/10.2169/internalmedicine.4562-20.
Crowe HM, Levitz RE. Invasive Haemophilus influenzae disease in adults. Arch Intern Med. 1987;147:241–4. https://doi.org/10.1001/archinte.1987.00370020061037.
Cevik M, Moncayo-Nieto OL, Evans MJ. Non-typeable Haemophilus influenzae-associated early pregnancy loss: an emerging neonatal and maternal pathogen. Infection. 2020;48:285–8. https://doi.org/10.1007/s15010-019-01359-6.
Brouwer MC, van de Beek D, Hcckenberg SGB, Spanjaard L, de Gans J. Community-acquired Haemophilus influenzae meningitis in adults. Clin Microbiol Infect. 2007;13:430–56. https://doi.org/10.1111/j.1469-0691.2006.01670.x.
Chekrouni N, Koelman DLH, Brouwer MC, der Ende V, van de Beek D. Common-acquired Haemophilus influenzae meningitis in adults. J Infect. 2021;82:145–50. https://doi.org/10.1016/j.jinf.2021.03.016.
Gattarello S, Lagunes L, Vidauri L, Sole-Violan J, Zaragoza R, Valles J, et al. Improvement of antibiotic therapy and ICU survival in severe non-pneumococcal community-acquired pneumonia: a matched case-control study. Crit Care. 2015;19:335. https://doi.org/10.1186/s13054-015-1051-1.
Murphy TF. Vaccines for nontypeable Haemophilus influenzae: the future is now. Clin Vaccine Immunol. 2015;22:459–66. https://doi.org/10.1128/CVI.00089-15.
Cerquetti M, Giufre M. Why we need a vaccine for non-typeable Haemophilus influenzae. Human Vaccin Immunother. 2016;12:2357–61. https://doi.org/10.1080/21645515.2016.1174354.
Acknowledgements
We sincerely thank the staff of the local public health centers who collected bacterial isolates and case report forms from the hospitals and the staff of the public health institutes and laboratories who worked for the Adult IHD Study Group (https://www.nih.go.jp/niid/ja/ibi.html). In addition to the authors, the following investigators and institutions participated in the Adult IPD Study Group: Akihito Yokoyama of Kochi Medical School, Kochi University; Hiroki Takahashi of Sapporo Medical University School of Medicine; Hiroaki Takeda of Yamagata Saiseikai Hospital; Chikako Tsubata of Niigata University Graduate School of Medical and Dental Sciences; Masayuki Ishida of Chikamori Hospital; Masashi Nakamatsu of University of the Ryukus; Masahiro Satou of Hokkaido Institute of Public Health; Yu Suzuki, Junji Seto, and Kazue Yahagi of Yamagata Prefectural Institute of Public Health; Satoru Yamazaki and Emiko Kumakura of Health and Sanitation Department of Niigata City; Yuhki Nagai and Sagako Naraya of Department of Health and Welfare, Mie Prefecture Health and Environment Research Institute; Mie Uchida, Junko Tanabe, Miyuki Saeki, and Takako Yoshida of Nara Prefecture Health and Environmental Institute; Akihiko Tokaji of The Public Health Institute of Kochi Prefecture; Hiroaki Shigemura, Fuyuki Okamoto, and Nobuyuki Sera of Fukuoka Institute of Health and Environmental Science; Mutsuyo Gokuden of Center for Environment and Health, Kagoshima Prefecture; Jun Kudaka of Okinawa Prefectural Institute of Health and Environment; Junko Isobe and Junichi Kanatani of Department of Bacteriology, Toyama Institute of Health.
Funding
This work was supported by Ministry of Health, Labour and Welfare HA Program Grant Number JPMH19HA1005.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
The authors have no financial interests relevant to this article to disclose.
Ethical approval
This study was reviewed and approved by the Medical Research Ethics Committee of NIID for the Use of Medical Subjects (no. 707) and was conducted in accordance with the principles expressed in the Declaration of Helsinki. The need for informed consent was waived because the data did not contain any patient identifiers and all samples were taken as part of standard patient care.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hachisu, Y., Tamura, K., Murakami, K. et al. Invasive Haemophilus influenzae disease among adults in Japan during 2014–2018. Infection 51, 355–364 (2023). https://doi.org/10.1007/s15010-022-01885-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-022-01885-w